Curran Terrie 4
4 · Phathom Pharmaceuticals, Inc. · Filed Nov 3, 2023
Insider Transaction Report
Form 4
Curran Terrie
DirectorPresident and Chief Executive
Transactions
- Award
Common Stock
2023-11-01+37,500→ 427,171 total
Holdings
- 3,579.61(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Represents shares earned with respect to performance stock unit awards granted on July 1, 2020 and January 19, 2023 that contained a performance-vesting requirement that was satisfied on November 1, 2023.